Pierquet, G.
Prévost, E.
Lopez, L.
Gaston, R.
Rouffilange, J.
Riviere, J.
Roche, JB
Vuong, N.
Genty, A.
Hoepffner, J. L.
Asimakopoulos, A.D
Piechaud, PT
Funding for this research was provided by:
ELSAN
Article History
Received: 8 October 2025
Accepted: 2 November 2025
First Online: 15 November 2025
Declarations
:
: The authors declare no competing interests.
: The “Groupement de Coopération Sanitaire ELSAN” is the promoter of the “Enhanced Recovery Program After a Robotic-assisted Surgery (RAAC) of Radical Prostatectomy (PROSTA-RAAC)” study, which was done in accordance with Good Clinical Practices and the Declaration of Helsinki. This study is registered with the ANSM (Agence Nationale de Surveillance du Médicament) under the IDRCB: 2020-A03292-37. It was approved by the ethics committee (CPP du Sud-Ouest et Outre-mer) on 25/03/2021, and written informed consent was obtained for each participant. A commitment to comply with the data processing reference methodology MR-001 was declared to the CNIL on 21/07/2020 per the General Data Protection Regulation (GDPR). The management and processing of the data was carried out by the DPO (Data Protection Officer) of ELSAN. The trial was registered on 21/12/2021 on the ClinicalTrials.gov database (NCT05172986).
: All participants were informed of the study details and signed a written consent form before being included in the study.